Equities

Pulsion Medical Systems SE

PUS:MUN

Pulsion Medical Systems SE

Actions
Health CareMedical Equipment and Services
  • Price (EUR)17.50
  • Today's Change0.00 / 0.00%
  • Shares traded301.00
  • 1 Year change-2.78%
  • Beta0.0632
Data delayed at least 15 minutes, as of Apr 25 2024 07:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pulsion Medical Systems SE is a Germany-based company that develops and markets minimally invasive physiological monitoring systems for use in intensive care stations and in operating rooms. The Company's products are used primarily to monitor blood circulatory systems in patients. Pulsion also markets disposable measuring catheters and the intravenous diagnostic dye Indocyanine Green. The Company operates worldwide. On February 19, 2014, Getinge AB secured 78.55% of the outstanding shares in Pulsion Medical Systems SE.

  • Revenue in EUR (TTM)31.67m
  • Net income in EUR5.41m
  • Incorporated2011
  • Employees66.00
  • Location
    Pulsion Medical Systems SEHans-Riedl-Str. 21FELDKIRCHEN 85622GermanyDEU
  • Phone+49 894599140
  • Fax+49 8 945991418
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Carmat SA895.00k-54.36m100.78m177.00------112.60-2.25-2.250.0369-0.38170.01231.580.20295,000.00-74.73-76.92-89.51-93.77-3,232.74---6,074.19-9,203.392.81-14.251.18---84.52--13.24---10.97--
Mercator Medical SA108.38m-53.56m103.40m1.29k--0.4564--0.9541-23.80-23.8048.7292.240.41252.545.35363,078.80-20.7529.67-22.1136.780.488538.55-50.3023.595.67-40.080.0062.49-68.5912.52-142.43--8.36--
C Rad AB36.48m3.95m108.84m84.0028.374.6123.072.981.361.3612.558.341.144.453.82--12.415.8717.408.0645.4543.0110.865.602.48287.500.00640.0040.9117.43516.3916.82----
Meditera Tibbi Mlzm Sny Tcrt AS41.71m742.94k112.79m728.00151.822.6349.422.700.21740.217412.2012.530.76782.925.311,994,873.001.379.371.5911.5444.3343.511.789.852.83--0.0552181.79-8.9948.75-77.3815.68----
Bastide Le Confort Medical SA523.32m6.32m122.65m3.55k22.851.511.490.23440.72990.77265.5711.020.79555.446.90147,580.701.842.492.663.5250.5448.822.313.050.8111.920.8391--8.4811.9411.2417.556.98--
Oncosem Onkolojik Sistemlr Sny v Tcrt AS6.91m-2.29m122.96m324.00--18.48--17.80-3.44-3.4410.159.720.69932.473.93742,302.40-23.20---31.86--14.88---33.18--1.30--0.2087---17.90---284.37------
Sedana Medical AB (publ)13.22m-5.12m124.27m79.00--1.49--9.40-0.6001-0.60011.559.760.14691.107.691,947,696.00-5.69-5.77-5.95-6.0870.8364.06-38.74-36.139.68--0.0044--25.2321.5918.90--42.12--
ADDvise Group AB (publ)126.81m9.52m142.99m620.0023.283.257.421.130.58640.58647.844.200.55066.735.522,365,224.004.143.725.174.7747.6348.957.515.891.092.990.66080.940544.3038.6227.62--30.35--
Pulsion Medical Systems SE31.67m5.41m144.40m66.0026.725.2121.234.560.65490.65493.843.360.97111.773.88479,840.0016.5820.3721.2431.1763.6655.9617.0724.121.7715.740.001,227.726.103.02-8.06----0.00
Amplitude Surgical SA104.05m43.23m145.98m416.003.381.542.671.400.90020.90022.171.970.39550.56528.83244,244.1016.21-0.365819.44-0.426779.4178.3040.98-1.081.210.41630.5395--14.44-0.0271993.58--7.11--
Stille AB25.34m2.29m147.07m106.0035.871.5141.755.805.315.3158.76126.110.514----2,782,019.004.647.035.218.1944.8243.939.049.856.543.360.0021.9819.7016.78-2.485.3423.62--
Onward Medical NV0.00-36.06m167.95m96.00--4.27-----1.19-1.190.001.140.00----0.00-47.61---52.97-------------32.110.3163------4.49------
Prim SA216.51m12.67m173.77m900.0013.691.387.650.80260.7450.74512.737.401.121.994.10240,567.406.586.689.248.9037.9338.115.856.431.22--0.1681--9.7710.0051.02-2.1412.86--
Bactiguard Holding AB19.17m-11.89m181.90m217.00--6.77--9.49-3.95-3.956.3710.080.30374.376.931,028,447.00-18.83-7.56-24.62-8.8127.4747.91-62.01-26.280.6445-8.670.3976---11.966.46-161.71--8.43--
Data as of Apr 25 2024. Currency figures normalised to Pulsion Medical Systems SE's reporting currency: Euro EUR

Institutional shareholders

3.21%Per cent of shares held by top holders
HolderShares% Held
TBF Global Asset Management GmbHas of 31 Dec 2022110.03k1.33%
Discover Capital GmbHas of 30 Jun 202350.00k0.61%
VM Verm�gens-Management GmbHas of 30 Apr 202343.90k0.53%
Axxion SA (Luxembourg)as of 31 Mar 202340.00k0.49%
PEH Wertpapier AG (Germany)as of 29 Feb 202410.01k0.12%
FIS Privatbank S.A.as of 30 Apr 20238.22k0.10%
MFC Asset Management Public Co., Ltd. (Investment Management)as of 31 Oct 20231.42k0.02%
Greiff Capital Management AGas of 30 Jun 20221.10k0.01%
Knoesel & Ronge Verm�gensverwaltung GmbH & Co. KGas of 28 Feb 20230.000.00%
More ▼
Data from 28 Feb 2023 - 28 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.